US 7,517,889 B2
	2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists
Keith John Harris, Chester, N.J. (US); and Bin Cao, Bedminster, N.J. (US)
Assigned to Aventis Pharmaceuticals, Inc., Bridgewater, N.J. (US)
Filed on Apr. 16, 2007, as Appl. No. 11/735,760.
Application 11/735760 is a continuation of application No. PCT/US2005/037148, filed on Oct. 14, 2005.
Claims priority of provisional application 60/619272, filed on Oct. 15, 2004.
Prior Publication US 2007/0265291 A1, Nov. 15, 2007
Int. Cl. C07D 239/46 (2006.01); A61K 31/505 (2006.01)

U.S. Cl. 514—274  [544/313]

13 Claims

1. A compound, which is 2-(3-{6-[2-(2,4-dichloro-phenyl)-ethylamino]-2-methoxy-pyrimidin-4-yl}-phenyl)-2-methyl-propionic acid, or an N-oxide thereof, an ester prodrug thereof, or a pharmaceutically acceptable salt thereof.